Skip to content

Investments at other companies

Principal Financial Group logo
Principal Financial GroupPFG
$110.86B+5.3%
CVS Health logo
CVS HealthCVS
$32.41B+12.1%
Cigna logo
CignaCI
$18.9B+23.1%
Monster Beverage logo
Monster BeverageMNST
$770.4M
EVERTEC logo
EVERTECEVTC
$6.1M+16.2%
Dominion Energy logo
Dominion EnergyD
$9.47B+13.1%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:Investments.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's investments?
Ginkgo Bioworks (DNA) reported investments of $14.7M in Q1 2026.
How has Ginkgo Bioworks's investments changed year-over-year?
Ginkgo Bioworks's investments decreased by 54.3% year-over-year, from $32.17M to $14.7M.
What is the long-term trend for Ginkgo Bioworks's investments?
Over 5 years (2020 to 2025), Ginkgo Bioworks's investments has grown at a -27.3% compound annual growth rate (CAGR), from $74.2M to $15.07M.